Traditional scoring systems, including Child–Pugh, Albumin–Bilirubin, Model for End-Stage Liver Disease (MELD), MELD-Na, MELD 3.0, and Alpha-fetoprotein scores, are widely used but often fail to provide precise risk assessments. This evidence concerns the gene ALB and End Stage Liver Disease.